Frederick Beddingfield III, Chief Medical Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 2,041 shares at $45.51 ($93K) on 2015-04-30, disclosed to the SEC on 2015-04-30.
Open-market sale of $93k KYTH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KYTH | SELL | 2015-06-25 | $2.3M | — | Filing → |